Posted on:
A collection of emerging research leaders will have the chance to broaden their research experience thanks to funding provided through the Skipper Jacobs Charitable Trust. Close to $40,000 will be shared amongst five early-to-mid career researchers, allowing them to travel nationally and internationally expanding their research and developing new skills. It’s anticipated the travel program…
Posted on:
With an increasing number of people suffering anterior cruciate ligament (ACL) injuries, researchers at the Kolling Institute say a broader range of tendon grafts could be successfully adopted by surgeons undertaking knee reconstructions. The research, which is the second-largest human tendon study ever published, is prompting calls for tissue banks to review current age restrictions…
Posted on:
We would like to congratulate Professor Chris Little who has received a highly coveted award for his outstanding commitment to orthopaedic research. Professor Little has been elected a Fellow of International Orthopaedic Research at a key international conference in Edinburgh Scotland. The award is only presented every three years, with around 20 people across the…
Posted on:
A $400,000 robot which may hold the key to significant improvements in hip and knee replacements is now operational at the Kolling Institute. Known as KOBRA or the Kolling Orthopaedic Biomechanics Robotic Arm, the new technology delivers an advanced testing facility, while greatly increasing research capabilities. It is the largest of its kind in Australia…
Posted on:
Kolling Institute researchers have helped map out exciting future developments for the rehabilitation of hip and knee replacement patients. A team of researchers from Sydney Musculoskeletal Health – a partnership between the University of Sydney, Sydney Local Health District and Northern Sydney Local Health District – recently attended the International Society for Technology in Arthroplasty’s…
Posted on:
Arthritis is the third most prevalent long-term health condition in Australia affecting more than 12 per cent of Australians. There is no cure for arthritis, with treatment options largely focused on alleviating pain, including pain relief medication, arthroscopy or joint replacement. Australia is at the forefront of clinical research and trials, which is helping the…
Posted on:
Ambitious leadership, functional wellbeing and a passion for collaboration An international healthcare destination celebrated for its collaborative spirits and dedication to human health and wellbeing. This is Professor Jim Elliott’s vision for how the collaboration between the Kolling Institute, the Faculty of Medicine and Health and the Northern Sydney Local Health District will evolve. Highly…
Posted on:
Our researchers are seeking participants for a large-scale clinical trial pioneering the use of stem cells to treat and potentially cure osteoarthritis. The disease is now one of the leading causes of disability in the world, affecting around three million people in Australia alone. Royal North Shore Hospital rheumatologist Professor David Hunter is leading the…
Posted on:
Researchers at the Kolling Institute are increasingly forging partnerships with industry, with the collaborative efforts accelerating improvements in patient care. One team which has particularly benefitted from a strong relationship with industry partners is the diverse group from the Murray Maxwell Biomechanics Laboratory. Director, Associate Professor Liz Clarke is encouraging others to follow suit, convinced…
Posted on:
The largest study in Australia into the treatment of juvenile arthritis may pave the way for a unique approach to care for those with the disabling condition and dramatically improve outcomes. The Medical Research Future Fund will invest $2.5 million in the A3BC for Kids project which will involve researchers from the Kolling Institute and…
Copyright © 2026 Kolling Institute
All rights reserved